The Conversation (0)
- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Top Stocks
Top Resource Stocks
Top Tech Stocks
Top Life Science Stocks
Trending
Trending Articles
Trending Press Releases
Trending Companies
Trending Reports
Resource
Popular Lists
Investing Ideas
Outlook Reports
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
Investing Guides
Tech
Popular Lists
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
Investing Ideas
Outlook Reports
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
Investing Guides
Life Science
Popular Lists
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
Outlook Reports
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Investing Guides
Aleafia Health (TSX:ALEF,OTCQX:ALEAF) announced Thursday (August 1) its subsidiary, Emblem Cannabis, has completed the largest adult-use cannabis order in the company’s history. As quoted in the press release: The value of the Order is expected to generate proceeds from the sale of cannabis exceeding $1.0 million, and has been shipped to a Canadian provincial government …
Aleafia Health (TSX:ALEF,OTCQX:ALEAF) announced Thursday (August 1) its subsidiary, Emblem Cannabis, has completed the largest adult-use cannabis order in the company’s history.
As quoted in the press release:
The value of the Order is expected to generate proceeds from the sale of cannabis exceeding $1.0 million, and has been shipped to a Canadian provincial government for distribution to online and retail consumers. The single Order features all of the Company’s product formats and 17 individual product SKUs.
Aleafia Health’s average monthly gross revenue generated from the sale of cannabis now consistently and significantly exceeds equivalent revenues generated during Aleafia Health’s entire 2018 annual reporting period.
“Our largest cannabis sale to date again points to the consistent, upwards trajectory of Aleafia Health as we grow and refine our vertically integrated production supply chain across three facilities,” said Aleafia Health CEO Geoffrey Benic.
Click here to read the full press release.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.